15,16 Meta-analyses have demonstrated that these agents are associated with reductions in AHI and improvements in sleep-related outcomes in patients with obesity-related OSA
A variety of GLP-1 receptor agonists were evaluated across the studies, including exenatide (daily or weekly formulations), liraglutide (1.8 mg or 3.0 mg), dulaglutide, lixisenatide, oral and subcutaneous semaglutide, as well as the novel dual receptor agonist tirzepatide
Sixty-six percent of covered workers have a copayment for a primary care physician office visit and 22% have coinsurance
Antioxidants like Lycopene and Vitamin E reduce oxidative damage to blood vessels, which is a key contributor to atherosclerosis and hypertension
These morphological changes are accompanied by functional disruptions, including impaired performance of respiratory chain complexes I and III